Probiotic supplementation for preventing invasive fungal infections in preterm neonates - A systematic review and meta-analysis

Mycoses

Volumn 58, Issue 11, 2015, Pages 642-651

  Agrawal, Sachin ^a,b,c   Rao, Shripada ^a,b,c   Patole, Sanjay ^a,b,c  

^a KEM Hospital for Women   (Australia)

^b PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Infants; Neonates; Preterm; Probiotic supplementation; Review

Indexed keywords

NYSTATIN; PROBIOTIC AGENT;

DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG SAFETY; FUNGAL COLONIZATION; HUMAN; META ANALYSIS; OUTCOME ASSESSMENT; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; SYSTEMIC MYCOSIS; DIETARY SUPPLEMENT; INFANT, PREMATURE, DISEASES; MICROBIOLOGY; MYCOSES; NEWBORN; VERY LOW BIRTH WEIGHT;

DIETARY SUPPLEMENTS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; INFANT, VERY LOW BIRTH WEIGHT; MYCOSES; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84944458313     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/myc.12368     Document Type: Review

References (71)

1. Benjamin DK Jr, Stoll BJ, Gantz MG et al. Neonatal candidiasis: epidemiology, risk factors, and clinical judgment. Pediatrics 2010; 126: 865-73.
2. Aliaga S, Clark RH, Laughon M et al. Changes in the incidence of candidiasis in neonatal intensive care units. Pediatrics 2014; 133: 236-42.
3. Hundalani S, Pammi M. Invasive fungal infections in newborns and current management strategies. Expert Rev Anti Infect Ther 2013; 11: 709-21.
4. Shane AL, Stoll BJ. Recent developments and current issues in the epidemiology, diagnosis, and management of bacterial and fungal neonatal sepsis. Am J Perinatol 2013; 30: 131-41.
5. Hsieh E, Smith PB, Jacqz-Aigrain E et al. Neonatal fungal infections: when to treat? Early Hum Dev 2012; 88: S6-10.
6. Benjamin DK Jr, Hudak ML, Duara S et al. Effect of fluconazole prophylaxis on candidiasis and mortality in premature infants: a randomized clinical trial. JAMA 2014; 311: 1742-9.
7. Manzoni P, Stronati M, Jacqz-Aigrain E et al. Correct choices for correct treatments: key issues in the management of Candida infections in preterm neonates. Early Hum Dev 2012; 88: S98-100.
8. Austin N, Darlow BA, McGuire W. Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants. Cochrane Database Sys Rev 2013; 3: CD003478.
9. Tripathi N, Watt K, Benjamin DK Jr. Treatment and prophylaxis of invasive candidiasis. Semin Perinatol 2012; 36: 416-23.
10. Kaufman D, Boyle R, Hazen KC, Patrie JT, Robinson M, Donowitz LG. Fluconazole prophylaxis against fungal colonisation and infection in preterm infants. N Engl J Med 2001; 345: 1660-6.
11. Kicklighter SD, Springer SC, Cox T, Hulsey TC, Turner RB. Fluconazole for prophylaxis against candidal rectal colonization in the very low birth weight infant. Pediatrics 2001; 107: 293-8.
12. Manzoni P, Stolfi I, Pugni L et al. A multicenter, randomized trial of prophylactic fluconazole in preterm neonates. N Engl J Med 2007; 356: 2483-95.
13. Parikh TB, Nanavati RN, Patankar CV et al. Fluconazole prophylaxis against fungal colonization and invasive fungal infection in very low birth weight infants. Indian Pediatr 2007; 44: 830-7.
14. Mersal A, Alzahrani I, Azzouz M et al. Oral nystatin versus intravenous fluconazole as neonatal antifungal prophylaxis: non-inferiority trial. J Clini Neonatol 2013; 2: 88-92.
15. Aydemir C, Oguz SS, Dizdar EA et al. Randomised controlled trial of prophylactic fluconazole versus nystatin for the prevention of fungal colonisation and invasive fungal infection in very low birth weight infants. Arch Dis Child Fetal Neonatal Ed 2011; 96: F164-8.
16. Pfaller MA. Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment. Am J Med 2012; 125(Suppl 1): S3-13.
17. Arendrup MC. Candida and candidaemia, Susceptibility and epidemiology. Dan Med J 2013; 60: B4698.
18. FAO/WHO Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. 2001. URL http://www.who.int/foodsafety/publications/fs_management/en/probiotics.pdf [accessed on 4 June 2012].
19. AlFaleh K, Anabrees J. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev 2014; 4: CD005496.
20. Romeo MG, Romeo DM, Trovato L et al. Role of probiotics in the prevention of the enteric colonisation by Candida in preterm newborns: incidence of late-onset sepsis and neurological outcome. J Perinatol 2011; 31: 63-9.
21. Manzoni P, Mostert M, Leonessa ML et al. Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonisation by Candida species in preterm neonates: a randomized study. Clin Infect Dis 2006; 42: 1735-42.
22. Manzoni P. Use of Lactobacillus casei subspecies Rhamnosus GG and gastrointestinal colonisation by Candida species in preterm neonates. J Pediatr Gastroenterol Nutr 2007; 45: S190-4.
23. Kumar S, Bansal A, Chakrabarti A, Singhi S. Evaluation of efficacy of probiotics in prevention of candida colonization in a PICU-a randomized controlled trial. Crit Care Med 2013; 41: 565-72.
24. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. URL www.cochrane-handbook.org. [accessed on 10 September 2014].
25. Centre for Reviews and Dissemination. CRD's guidance for undertaking reviews in health care. URL www.york.ac.uk/inst/crd/systematicreviewsbook.htm. [accessed on 10 September 2014].
26. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009; 339: b2535.
27. Higgins JP, Altman DG, Gotzsche PC et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011; 343: d5928.
28. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-58.
29. Sterne JA, Sutton AJ, Ioannidis JP et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 2011; 343: d4002.
30. Al-Hosni M, Duenas M, Hawk M et al. Probiotics-supplemented feeding in extremely low-birth-weight infants. J Perinatol 2012; 32: 253-9.
31. Demirel G, Celik IH, Erdeve O, Saygan S, Dilmen U, Canpolat FE. Prophylactic Saccharomyces boulardii versus nystatin for the prevention of fungal colonization and invasive fungal infection in premature infants. Eur J Pediatr 2013; 172: 1321-6.
32. Roy A, Chaudhuri J, Sarkar D, Ghosh P, Chakraborty S. Role of enteric supplementation of probiotics on late-onset sepsis by Candida species in preterm low birth weight neonates: a randomized, double blind, placebo-controlled trial. N Am J Med Sci 2014; 6: 50-7.
33. Sari FN, Dizdar EA, Oguz S, Erdeve O, Uras N, Dilmen U. Oral probiotics: Lactobacillus sporogenes for prevention of necrotizing enterocolitis in very low-birth weight infants: a randomized, controlled trial. Eur J Clin Nutr 2011; 65: 434-9.
34. Patole S, Keil AD, Chang A et al. Effect of Bifidobacterium breve M-16V supplementation on fecal bifidobacteria in preterm neonates-a randomised double blind placebo controlled trial. PLoS ONE 2014; 9: e89511.
35. Oncel MY, Arayici S, Sari FN et al. Comparison of Lactobacillus reuteri and nystatin prophylaxis on Candida colonization and infection in very low birth weight infants. J Matern Fetal Neonatal Med 2014; 28: 1-5 [Epub ahead of print].
36. Bin-Nun A, Bromiker R, Wilschanski M et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J Pediatr 2005; 147: 192-6.
37. Braga TD, da Silva GA, de Lira PI, de Carvalho Lima M. Efficacy of Bifidobacterium breve and Lactobacillus casei oral supplementation on necrotizing enterocolitis in very-low-birth-weight preterm infants: a double-blind, randomized, controlled trial. Am J Clin Nutr 2011; 93: 81-6.
38. Costalos C, Skouteri V, Gounaris A et al. Enteral feeding of premature infants with Saccharomyces boulardii. Early Hum Dev 2003; 74: 89-96.
39. Dani C, Biadaioli R, Bertini G, Martelli E, Rubaltelli FF. Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biol Neonate 2002; 82: 103-8.
40. Demirel G, Erdeve O, Celik IH, Dilmen U. Saccharomyces boulardii for prevention of necrotizing enterocolitis in preterm infants: a randomized, controlled study. Acta Paediatr 2013; 102: e560-5.
41. Fernandez-Carrocera LA, Solis-Herrera A, Cabanillas-Ayon M et al. Double-blind, randomised clinical assay to evaluate the efficacy of probiotics in preterm newborns weighing less than 1500 g in the prevention of necrotising enterocolitis. Arch Dis Child Fetal Neonatal Ed 2013; 98: F5-9.
42. Kitajima H, Sumida Y, Tanaka R, Yuki N, Takayama H, Fujimura M. Early administration of Bifidobacterium breve to preterm infants: randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 1997; 76: F101-7.
43. Li Y, Shimizu T, Hosaka A, Kaneko N, Ohtsuka Y, Yamashiro Y. Effects of bifidobacterium breve supplementation on intestinal flora of low birth weight infants. Pediatr Int 2004; 46: 509-15.
44. Lin HC, Hsu CH, Chen HL et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial. Pediatrics 2008; 122: 693-700.
45. Mihatsch WA, Vossbeck S, Eikmanns B, Hoegel J, Pohlandt F. Effect of Bifidobacterium lactis on the incidence of nosocomial infections in very-low-birth-weight infants: a randomized controlled trial. Neonatology 2010; 98: 156-63.
46. Millar MR, Bacon C, Smith SL, Walker V, Hall MA. Enteral feeding of premature infants with Lactobacillus GG. Arch Dis Child 1993; 69: 483-7.
47. Mohan R, Koebnick C, Schildt J et al. Effects of Bifidobacterium lactis Bb12 supplementation on intestinal microbiota of preterm infants: a double-blind, placebo-controlled, randomized study. J Clin Microbiol 2006; 44: 4025-31.
48. Reuman PD, Duckworth DH, Smith KL, Kagan R, Bucciarelli RL, Ayoub EM. Lack of effect of Lactobacillus on gastrointestinal bacterial colonization in premature infants. Pediatr Infect Dis 1986; 5: 663-8.
49. Rojas MA, Lozano JM, Rojas MX et al. Prophylactic probiotics to prevent death and nosocomial infection in preterm infants. Pediatrics 2012; 130: e1113-20.
50. Rouge C, Piloquet H, Butel MJ et al. Oral supplementation with probiotics in very-low-birth-weight preterm infants: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr 2009; 89: 1828-35.
51. Samanta M, Sarkar M, Ghosh P, Ghosh J, Sinha M, Chatterjee S. Prophylactic probiotics for prevention of necrotizing enterocolitis in very low birth weight newborns. J Trop Pediatr 2009; 55: 128-31.
52. Stratiki Z, Costalos C, Sevastiadou S et al. The effect of a bifidobacter supplemented bovine milk on intestinal permeability of preterm infants. Early Hum Dev 2007; 83: 575-9.
53. Jacobs SE, Tobin JM, Opie GF et al. Probiotic effects on late-onset sepsis in very preterm infants: a randomized controlled trial. Pediatrics 2013; 132: 1055-62.
54. Lin HC, Su BH, Chen AC et al. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics 2005; 115: 1-4.
55. Jacquot A, Neveu D, Aujoulat F et al. Dynamics and clinical evolution of bacterial gut microflora in extremely premature patients. J Pediatr 2011; 158: 390-6.
56. Fouhy F, Guinane CM, Hussey S et al. High-throughput sequencing reveals the incomplete, short-term recovery of infant gut microbiota following parenteral antibiotic treatment with ampicillin and gentamicin. Antimicrob Agents Chemother 2012; 56: 5811-20.
57. Unger S, Stintzi A, Shah P, Mack D, O'Connor DL. Gut microbiota of the very-low-birth-weight infant. Pediatr Res 2015; 77: 205-13.
58. el-Mohandes AE, Johnson-Robbins L, Keiser JF, Simmens SJ, Aure MV. Incidence of Candida parapsilosis colonization in an intensive care nursery population and its association with invasive fungal disease. Pediatr Infect Dis J 1994; 13: 520-4.
59. Huang YC, Li CC, Lin TY et al. Association of fungal colonization and invasive disease in very low birth weight infants. Pediatr Infect Dis J 1998; 17: 819-22.
60. Manzoni P, Farina D, Galletto P et al. Type and number of sites colonized by fungi and risk of progression to invasive fungal infection in preterm neonates in neonatal intensive care unit. J Perinat Med 2007; 35: 220-6.
61. Wagner RD, Pierson C, Warner T, Dohnalek M, Hilty M, Balish E. Probiotic effects of feeding heat-killed Lactobacillus acidophilus and Lactobacillus casei to Candida albicans-colonized immunodeficient mice. J Food Prot 2000; 63: 638-44.
62. Wagner RD1, Pierson C, Warner T et al. Biotherapeutic effects of probiotic bacteria on candidiasis in immunodeficient mice. Infect Immun 1997; 65: 4165-72.
63. Deshpande G, Rao S, Patole S. Probiotics for prevention of necrotising enterocolitis in preterm neonates with very low birthweight: a systematic review of randomised controlled trials. Lancet 2007; 369: 1614-20.
64. Wang Q, Dong J, Zhu Y. Probiotic supplement reduces risk of necrotizing enterocolitis and mortality in preterm very low-birth-weight infants: an updated meta-analysis of 20 randomized, controlled trials. Pediatr Surg 2012; 47: 241-8.
65. Schmidt FL, Oh IS, Hayes TL. Fixed- versus random-effects models in meta-analysis: model properties and an empirical comparison of differences in results. J Math Stat Psychol 2009; 62(Pt 1): 97-128.
66. Bertelli C, Pillonel T, Torregrossa A, Prod'hom G et al. Bifidobacterium longum bacteremia in preterm infants receiving probiotics. Clin Infect Dis 2015; 60: 924-7.
67. Thompson C, McCarter YS, Krause PJ, Herson VC. Lactobacillus acidophilus sepsis in a neonate. J Perinatol 2001; 21: 258-60.
68. Perapoch J, Planes AM, Querol A et al. Fungemia with Saccharomyces cerevisiae in two newborns, only one of whom had been treated with ultra-levura. Eur J Clin Microbiol Infect Dis 2000; 19: 468-70.
69. Fouhy F, Ross RP, Fitzgerald GF, Stanton C, Cotter PD. Composition of the early intestinal microbiota: knowledge, knowledge gaps and the use of high-throughput sequencing to address these gaps. Gut Microbes 2012; 3: 203-20.
70. Vallabhaneni S, Walker TA, Lockhart SR et al. Notes from the field: Fatal gastrointestinal mucormycosis in a premature infant associated with a contaminated dietary supplement-Connecticut, 2014. MMWR Morb Mortal Wkly Rep 2015; 64: 155-6.
71. Deshpande G, Rao S, Patole S. Probiotics in neonatal intensive care - Back to the future. Aust N Z J Obstet Gynaecol 2015; 55: 210-17.